Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033 The global market for viral vectors and plasmid DNA manufacturing is set to reach $34 billion by 2033, driven by growth in gene therapy and rising disease prevalence.

Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033 #USA #gene_therapy #Portland #Plasmid_DNA #viral_vectors

Bionova Scientific and Syenex Form Alliance for Enhanced Gene Therapy Deliveries Bionova Scientific and Syenex have teamed up to enhance global access to high-quality plasmid DNA, pivotal for advanced gene therapies.

Bionova Scientific and Syenex Form Alliance for Enhanced Gene Therapy Deliveries #United_States #Houston #Syenex #Bionova_Scientific #Plasmid_DNA

VGXI Achieves Key FDA Inspection Success, Boosting Plasmid DNA Manufacturing Leadership VGXI, a leader in plasmid DNA biopharmaceuticals, marks a significant achievement with FDA approval for a client's BLA following a successful inspection.

VGXI Achieves Key FDA Inspection Success, Boosting Plasmid DNA Manufacturing Leadership #USA #Plasmid_DNA #VGXI_Inc #Biologics_License_Application #Conroe

ProBio Introduces Innovative GMP Plasmid DNA Manufacturing Services for Biopharma ProBio's latest GMP Plasmid DNA service ensures fast delivery and high quality, drastically reducing timelines for clinical development. Read more!

ProBio Introduces Innovative GMP Plasmid DNA Manufacturing Services for Biopharma #USA #ProBio #Hopewell #Plasmid_DNA #GMP_Manufacturing